Sudden sensorineural hearing loss: Difference between revisions
Ostermayer (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | |||
===Epidemiology=== | ===Epidemiology=== | ||
*Mostly idiopathic | *Mostly idiopathic | ||
| Line 6: | Line 7: | ||
*Men and women affected equally | *Men and women affected equally | ||
==Clinical Manifestations== | |||
*Immediate/rapid hearing loss or hearing loss upon awakening | *Immediate/rapid hearing loss or hearing loss upon awakening | ||
*Mostly unilateral hearing loss | *Mostly unilateral hearing loss | ||
| Line 16: | Line 17: | ||
*No sign of obstruction or OM on physical exam | *No sign of obstruction or OM on physical exam | ||
==Diagnosis== | |||
*[[Eponyms_(T-Z)#Weber_test|Weber test]] and [[Eponyms_(Q-S)#Rinne_test|Rinne test]] | *[[Eponyms_(T-Z)#Weber_test|Weber test]] and [[Eponyms_(Q-S)#Rinne_test|Rinne test]] | ||
*Otoscopic exam to r/o OM, OE, foreign bodies, perforated TM or cholesteatoma | *Otoscopic exam to r/o OM, OE, foreign bodies, perforated TM or cholesteatoma | ||
| Line 24: | Line 25: | ||
*MRI to r/o acoustic neuroma, perilymphatic fistula, Ménière’s disease, vascular insufficiency, MS | *MRI to r/o acoustic neuroma, perilymphatic fistula, Ménière’s disease, vascular insufficiency, MS | ||
==Differential Diagnoses== | |||
*Acute stroke, usually AICA occlusion | *Acute [[stroke]], usually AICA occlusion | ||
*[[Multiple Sclerosis]] | *[[Multiple Sclerosis]] | ||
*Meningitis | *[[Meningitis]] | ||
*Vestibular schwannomas | *Vestibular schwannomas | ||
*Migrainous infarction | *Migrainous infarction | ||
*Acute otitis media | *[[Acute otitis media]] | ||
*Traumatic TM rupture | *Traumatic TM rupture | ||
===Treatment=== | ===Treatment=== | ||
*Glucocorticoids orally (prednisone 1 mg/kg/day up to 60 mg maximum for 10-14 days or dexamethasone 300 mg daily for 3 days) | *Glucocorticoids orally ([[prednisone]] 1 mg/kg/day up to 60 mg maximum for 10-14 days or [[dexamethasone]] 300 mg daily for 3 days) | ||
*Glucocorticoids locally (intratympanic instillation, dexamethasone 10 to 24 mg/mL or methylprednisolone 30 to 40 mg/mL) if refractory to oral GCs | *Glucocorticoids locally (intratympanic instillation, [[dexamethasone]] 10 to 24 mg/mL or [[methylprednisolone]] 30 to 40 mg/mL) if refractory to oral GCs | ||
*Antivirals for possible HSV-1 infection (valacyclovir 1g TID or famciclovir 500mg TID) | *Antivirals for possible [[HSV-1]] infection ([[valacyclovir]] 1g TID or [[famciclovir]] 500mg TID) | ||
==Prognosis== | |||
*Spontaneous improvement is common | *Spontaneous improvement is common | ||
*Better prognosis if high- or low-frequency hearing loss pattern rather than flat across all frequencies | *Better prognosis if high- or low-frequency hearing loss pattern rather than flat across all frequencies | ||
| Line 45: | Line 46: | ||
*Worse in patients with vertigo | *Worse in patients with vertigo | ||
==Follow-Up== | |||
*Audiogram in six months after initial diagnosis | *Audiogram in six months after initial diagnosis | ||
*Possible auditory rehabilitation for patients with permanent hearing loss | *Possible auditory rehabilitation for patients with permanent hearing loss | ||
*Consider assistive hearing devices | *Consider assistive hearing devices | ||
==See Also== | |||
==Sources== | ==Sources== | ||
| Line 54: | Line 57: | ||
#Weber PC. Etiology of hearing loss in adults. In: UpToDate. Accessed Sept 22 2014. | #Weber PC. Etiology of hearing loss in adults. In: UpToDate. Accessed Sept 22 2014. | ||
#Molina, FJ. Hearing Loss, Chapter 18. Tintinalli’s Emergency Medicine. | #Molina, FJ. Hearing Loss, Chapter 18. Tintinalli’s Emergency Medicine. | ||
[[Category:ENT]] | |||
Revision as of 01:45, 2 October 2014
Background
Epidemiology
- Mostly idiopathic
- Prognosis depends on severity of hearing loss
- Incidence estimates range from 2-20 per 100,000 people per year
- Most commonly 43-53 years of age
- Men and women affected equally
Clinical Manifestations
- Immediate/rapid hearing loss or hearing loss upon awakening
- Mostly unilateral hearing loss
- Sensation of blocked or full ear, patient doesn’t recognize hearing is gone
- Difficulty in localizing sound
- Tinnitus is common
- Some patients report vertigo
- Occasionally ear pain is present
- No sign of obstruction or OM on physical exam
Diagnosis
- Weber test and Rinne test
- Otoscopic exam to r/o OM, OE, foreign bodies, perforated TM or cholesteatoma
- Remove impacted cerumen and re-examine
- Complete Neurologic Exam to r/o stroke
- Audiometric evaluation
- MRI to r/o acoustic neuroma, perilymphatic fistula, Ménière’s disease, vascular insufficiency, MS
Differential Diagnoses
- Acute stroke, usually AICA occlusion
- Multiple Sclerosis
- Meningitis
- Vestibular schwannomas
- Migrainous infarction
- Acute otitis media
- Traumatic TM rupture
Treatment
- Glucocorticoids orally (prednisone 1 mg/kg/day up to 60 mg maximum for 10-14 days or dexamethasone 300 mg daily for 3 days)
- Glucocorticoids locally (intratympanic instillation, dexamethasone 10 to 24 mg/mL or methylprednisolone 30 to 40 mg/mL) if refractory to oral GCs
- Antivirals for possible HSV-1 infection (valacyclovir 1g TID or famciclovir 500mg TID)
Prognosis
- Spontaneous improvement is common
- Better prognosis if high- or low-frequency hearing loss pattern rather than flat across all frequencies
- Around 2/3 of patients with SSHL will regain hearing in the affected ear
- Worse prognosis in older patients
- Worse in patients with vertigo
Follow-Up
- Audiogram in six months after initial diagnosis
- Possible auditory rehabilitation for patients with permanent hearing loss
- Consider assistive hearing devices
See Also
Sources
- Weber PC. Sudden sensorineural hearing loss. In: UpToDate. Accessed Sept 22 2014.
- Weber PC. Etiology of hearing loss in adults. In: UpToDate. Accessed Sept 22 2014.
- Molina, FJ. Hearing Loss, Chapter 18. Tintinalli’s Emergency Medicine.